ZTS
Zoetis Inc. Healthcare - Animal Health Investor Relations →
Zoetis Inc. (ZTS) closed at $114.16 as of 2026-05-01, trading 27.9% below its 200-week moving average of $158.33. This places ZTS in the extreme value zone. The stock is currently moving closer to the line, down from -26.6% last week. The 14-week RSI sits at 40, indicating neutral momentum.
Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.04 ratio) is neutral — neither side is clearly dominating.
Over the past 643 weeks of data, ZTS has crossed below its 200-week moving average 6 times. On average, these episodes lasted 21 weeks. Historically, investors who bought ZTS at the start of these episodes saw an average one-year return of +8.7%.
With a market cap of $48.2 billion, ZTS is a large-cap stock. The company generates a free cash flow yield of 3.7%. Return on equity stands at 66.0%, indicating strong profitability. The stock trades at 14.6x book value.
The company has been aggressively buying back shares, reducing its share count by 8.4% over the past three years.
Over the past 12.3 years, a hypothetical investment of $100 in ZTS would have grown to $417, compared to $497 for the S&P 500. ZTS has returned 12.3% annualized vs 13.9% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 19.9% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ZTS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ZTS Crosses Below the Line?
Across 6 historical episodes, buying ZTS when it crossed below its 200-week moving average produced an average return of +2.7% after 12 months (median +13.0%), compared to +19.2% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +9.2% vs +43.2% for the index.
Each line shows $100 invested at the moment ZTS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ZTS has crossed below its 200-week MA 6 times with an average 1-year return of +8.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 2014 | Jun 2014 | 20 | 9.6% | +40.6% | +298.9% |
| Sep 2022 | Jan 2023 | 16 | 12.7% | +18.8% | -20.6% |
| Oct 2023 | Nov 2023 | 2 | 6.6% | +16.5% | -24.3% |
| Mar 2024 | Jul 2024 | 15 | 15.3% | -2.4% | -30.4% |
| Nov 2024 | Dec 2024 | 3 | 0.3% | -30.1% | -33.4% |
| Dec 2024 | Ongoing | 72+ | 29.2% | Ongoing | -29.2% |
| Average | 21 | — | +8.7% | — |
Frequently Asked Questions
Is ZTS below its 200-week moving average?
Yes. As of 2026-05-01, Zoetis Inc. (ZTS) is trading 27.9% below its 200-week moving average of $158.33. The current price is $114.16.
What is ZTS's 200-week moving average price?
Zoetis Inc.'s 200-week moving average is $158.33 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ZTS drops below its 200-week moving average?
ZTS has crossed below its 200-week moving average 6 times in our data. On average, buying at that moment produced a one-year return of +8.7%. These dips have historically been decent entry points. These episodes lasted 21 weeks on average.
Is ZTS a good value right now?
Here's what our data says about ZTS as of 2026-05-01: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 40. Free cash flow yield is 3.7%. Return on equity is 66.0%. Price-to-book is 14.6x. This is not a buy or sell recommendation — always do your own research.
How does ZTS compare to the S&P 500?
Over the past 12.3 years, $100 invested in ZTS would have grown to $417, compared to $497 for the S&P 500. That's 12.3% annualized vs 13.9% for the index. ZTS has underperformed the broader market over this period.
Does ZTS pay a dividend?
Yes. Zoetis Inc. currently pays a dividend yield of 186.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01